EO Technics Leads Three KRX Growth Stocks With High Insider Ownership

The South Korean stock market has shown resilience, advancing in consecutive sessions with the KOSPI nearing the 2,870-point mark amid a global uplift influenced by strong technology sector performances. In such an environment, companies with high insider ownership can be particularly compelling as they often reflect a leadership's commitment to the company's success and alignment with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
ALTEOGEN (KOSDAQ:A196170)	26.6%	73.1%
Global Tax Free (KOSDAQ:A204620)	18.1%	72.4%
Seojin SystemLtd (KOSDAQ:A178320)	27.9%	58.7%
Fine M-TecLTD (KOSDAQ:A441270)	17.3%	36.4%
Park Systems (KOSDAQ:A140860)	33%	35.6%
UTI (KOSDAQ:A179900)	34.1%	122.7%
Vuno (KOSDAQ:A338220)	19.5%	105%
HANA Micron (KOSDAQ:A067310)	20%	96.3%
INTEKPLUS (KOSDAQ:A064290)	16.3%	77.4%
Techwing (KOSDAQ:A089030)	18.7%	77.8%

Click here to see the full list of 81 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

We'll examine a selection from our screener results.

EO Technics

Simply Wall St Growth Rating: ★★★★☆☆

Overview: EO Technics Co., Ltd. is a global manufacturer and supplier of laser processing equipment, with a market capitalization of approximately ₩2.46 billion.

Operations: The firm operates primarily in the laser processing equipment sector, generating revenue globally.

Insider Ownership: 30.7%

Revenue Growth Forecast: 19.9% p.a.

EO Technics, a growth company in South Korea, showcases a mixed investment profile with high insider ownership. While its earnings are projected to rise significantly at 47% annually, surpassing the Korean market's average of 29.7%, its return on equity is expected to remain low at 15.8%. The firm's revenue growth forecast at 19.9% annually also outpaces the market expectation of 10.8%. However, concerns include highly volatile share prices and declining profit margins from 16.4% to 11%.

• Click here to discover the nuances of EO Technics with our detailed analytical future growth report.

• Our comprehensive valuation report raises the possibility that EO Technics is priced higher than what may be justified by its financials.

KOSDAQ:A039030 Earnings and Revenue Growth as at Jul 2024

Advanced Nano Products

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Advanced Nano Products Co., Ltd. is a company based in South Korea that manufactures and sells high-tech materials for applications in displays, semiconductors, secondary batteries, and solar cells globally, with a market capitalization of approximately ₩1.33 trillion.

Operations: The company generates revenue from the production and sale of high-tech materials utilized in various sectors including displays, semiconductors, secondary batteries, and solar cells.

Insider Ownership: 22.6%

Revenue Growth Forecast: 54.2% p.a.

Advanced Nano Products, despite a challenging year with reduced net income from KRW 4.48 billion to KRW 1.15 billion and lower profit margins, remains poised for growth with revenue expected to increase by 54.2% annually. This growth surpasses the South Korean market's forecast of 10.8%. However, earnings are projected to grow at a slower pace of 22.24% annually compared to the market's 29.7%, and shareholder dilution has occurred over the past year, raising some concerns about future equity value retention.

• Dive into the specifics of Advanced Nano Products here with our thorough growth forecast report.

• Insights from our recent valuation report point to the potential overvaluation of Advanced Nano Products shares in the market.

KOSDAQ:A121600 Ownership Breakdown as at Jul 2024

ALTEOGEN

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biopharmaceutical company engaged in developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market capitalization of approximately ₩14.34 billion.

Operations: The company generates revenue primarily through the development of advanced biopharmaceutical products, including long-lasting biobetters and innovative antibody-drug conjugates.

Insider Ownership: 26.6%

Revenue Growth Forecast: 48.3% p.a.

ALTEOGEN, a South Korean biotech firm, is experiencing rapid growth with earnings and revenue forecasted to expand significantly above the market average at 73.1% and 48.3% per year respectively. Recently, it achieved a pivotal milestone by securing MFDS approval for Tergase®, leveraging its proprietary Hybrozyme™ Technology. Despite high insider ownership indicating strong confidence from management, investor caution is advised due to share dilution in the past year and substantial stock price volatility recently.

• Take a closer look at ALTEOGEN's potential here in our earnings growth report.

• Our expertly prepared valuation report ALTEOGEN implies its share price may be too high.

KOSDAQ:A196170 Ownership Breakdown as at Jul 2024

Make It Happen

• Dive into all 81 of the Fast Growing KRX Companies With High Insider Ownership we have identified here.

• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.

• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include KOSDAQ:A039030 KOSDAQ:A121600 and KOSDAQ:A196170.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com